Disclosed is the use of selected DPP-IV inhibitors for treating physiological functional disorders and reducing the risk of at-risk patient groups developing such functional disorders. Also disclosed is the use of said DPP-IV inhibitors in combination with other agents such that improved treatment results can be obtained. Said uses can be employed for producing corresponding medicaments.
申请公布号
WO2007128761(A2)
申请公布日期
2007.11.15
申请号
WO2007EP54270
申请日期
2007.05.03
申请人
BOEHRINGER INGELHEIM INTERNATIONAL GMBH;BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG;DUGI, KLAUS;HIMMELSBACH, FRANK;MARK, MICHAEL